PRIOBUDE -400

Product Description

Description:
PRIOBUDE-400 is a combination inhalation therapy containing Formoterol Fumarate (a long-acting bronchodilator) and Budesonide (a corticosteroid with anti-inflammatory properties). This formulation is specially designed for the management of asthma and chronic obstructive pulmonary disease (COPD), helping patients achieve better control over breathing difficulties and improving overall lung function.

Composition (per dose):

• Formoterol Fumarate “ 6 mcg (approx.)

• Budesonide “ 400 mcg (approx.)

Mechanism of Action:

• Formoterol Fumarate: Provides long-acting bronchodilation by relaxing airway smooth muscles, ensuring easier airflow and rapid relief of symptoms like wheezing and breathlessness.

• Budesonide: Reduces airway inflammation, swelling, and mucus formation, thus preventing asthma attacks and COPD exacerbations.

Indications:

• Asthma (when inhaled corticosteroid and long-acting bronchodilator combination therapy is required)

• Chronic Obstructive Pulmonary Disease (COPD) with reversible airway obstruction

• Long-term management of bronchospasm and airway inflammation

Key Benefits:

• Dual action: bronchodilation + anti-inflammatory effect

• Provides long-lasting relief from asthma and COPD symptoms

• Helps reduce frequency and severity of exacerbations

• Improves quality of life in patients with chronic respiratory conditions

Dosage & Administration:

• Use only as directed by a physician.

• Dosage depends on severity of the condition and patient response.

• Administered via inhalation route using a dry powder inhaler (DPI).

Safety Information:

• Not for relief of acute asthma attacks (use a short-acting bronchodilator instead).

• Regular monitoring and physician guidance required.

• Possible side effects include throat irritation, hoarseness, tremor, or headache.

• Rinse mouth after inhalation to reduce the risk of oral thrush.